These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11481918)

  • 1. [Drug expenditures and health insurance contributions increase. Control of budgetsis at risk].
    Jentsch P
    MMW Fortschr Med; 2001 Jul; 143(26-27):49-50. PubMed ID: 11481918
    [No Abstract]   [Full Text] [Related]  

  • 2. [Do pharmacists and the state increase drug costs?].
    Kaesback W
    MMW Fortschr Med; 1999 Dec; 141(48):54. PubMed ID: 10766548
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significant increase in health insurance contributions. Where does the 7 billion euro extra income go?].
    Stoschek J
    MMW Fortschr Med; 2007 Jan; 149(1-2):52-3. PubMed ID: 17619369
    [No Abstract]   [Full Text] [Related]  

  • 4. [Health care contract, economic options and budgeting in ambulatory care].
    Richter-Reichhelm M
    Z Arztl Fortbild Qualitatssich; 2000 Dec; 94(10):819-25; discussion 826-7. PubMed ID: 11190917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corner stones of health care reform discussion: "factually little has changed"].
    Jürgen W
    Pflege Z; 2006 Sep; 59(9):571-3. PubMed ID: 17009800
    [No Abstract]   [Full Text] [Related]  

  • 6. [Unfairly implicated as cost drivers. New drugs without a chance?].
    MMW Fortschr Med; 2004 Mar; 146(10):45. PubMed ID: 15347085
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmaceutical organization recommends to budget-concerned physicians: simply do without some prescriptions!].
    Vorderwulbecke U
    MMW Fortschr Med; 1999 Dec; 141(48):56. PubMed ID: 10766549
    [No Abstract]   [Full Text] [Related]  

  • 8. [The global budget. Hospitals develop into enterprises: advantages or disadvantages?].
    Hollenstein U
    Krankenpfl Soins Infirm; 2000; 93(6):25-7. PubMed ID: 11941759
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inadequate point values accepted by choice. How the North-Rhine health insurance executive turns up the heat on physicians].
    Wiedemann B
    MMW Fortschr Med; 2002 Sep; 144(38):53-5. PubMed ID: 12395707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with drug control in public health insurance medicine. Costs increase further and care becomes poorer].
    MMW Fortschr Med; 2003 Jul; 145(29-30):57. PubMed ID: 12958782
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insurance carriers want to lower fixed rates. Physicians must deal with the anger in their practices].
    MMW Fortschr Med; 2001 Feb; 143(6):48-9. PubMed ID: 11247367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Assessment of need for nursing care and assistance within the scope of the "personal nursing budget": "we must take this step" (interview by Katrin Balzer)].
    Gertsen W
    Pflege Z; 2006 Sep; 59(9):568-70. PubMed ID: 17009799
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lean years for patients].
    Klose G; Anlauf M
    MMW Fortschr Med; 2004 Dec; 146(51-52):16. PubMed ID: 15675237
    [No Abstract]   [Full Text] [Related]  

  • 14. [Declining costs].
    Neumaier J
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
    [No Abstract]   [Full Text] [Related]  

  • 15. [Concepts in hospital management and health care economics].
    Schmelzer A; Klask J; Münster P; Karatas A
    Laryngorhinootologie; 1999 May; 78(5):269-79. PubMed ID: 10412137
    [No Abstract]   [Full Text] [Related]  

  • 16. [Millions of old cost burdens. The time bomb of overdue drug budgets].
    Bossmann A
    Chirurg; 1998 Apr; 69(4):suppl 116-8. PubMed ID: 9612626
    [No Abstract]   [Full Text] [Related]  

  • 17. [A regression wave rolls toward us. How to defend yourself].
    MMW Fortschr Med; 1999 Oct; 141(43):48-50. PubMed ID: 10912124
    [No Abstract]   [Full Text] [Related]  

  • 18. [Politics and medicine in the 21st century--misunderstandings, insolvency or foolishness?].
    Erdmann E
    Herz; 2003 Mar; 28(2):166-8. PubMed ID: 12722707
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug utilization and pharmaceutical cost-containment in germany-perspectives 1 year after enactment of the GMG].
    Schlander M
    Med Klin (Munich); 2005 Jun; 100(6):314-24. PubMed ID: 15968483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [European court. Drug budgets of physicians remain reduced].
    MMW Fortschr Med; 2004 Mar; 146(13):57. PubMed ID: 15219133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.